- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Results
5
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
5 companies
Diaceutics
Market Cap: UK£114.7m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.36
7D
-14.2%
1Y
16.3%
Bioventix
Market Cap: UK£99.3m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£19.00
7D
0%
1Y
-49.3%
Auxly Cannabis Group
Market Cap: CA$209.0m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.15
7D
0%
1Y
342.9%
SNDL
Market Cap: US$448.1m
Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.
SNDL
US$1.76
7D
1.1%
1Y
-7.4%
BioGaia
Market Cap: SEK 10.0b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 98.70
7D
-2.4%
1Y
-6.0%